In 2017, a collaboration began between CBM Christian Blind Mission, Mengo Hospital Eye Clinic in Kampala, Uganda, and Saarland University’s Eye Clinic in Homburg/Saar, Germany. The partnership aimed to promote international cooperation in research, training, and clinical practice.
What started as a dialogue has since evolved into a multi-year partnership focused on advancing ophthalmology in Uganda through infrastructure, expertise, and cross-continent knowledge exchange—proving that sustainable change is possible when institutions unite around shared goals. This partnership not only establishes a foundation for long-term improvements in the field of ophthalmology in Uganda, it also means better treatment, more trained specialists, and, ultimately, giving people the gift of sight.
.jpg)
A catalyst for advancements in cornea transplant
Earlier in the year, Prof. Dr Berthold Seitz, Director of Ophthalmology at Saarland University and a globally renowned expert in corneal transplants visited Mengo Hospital to review ongoing projects and explore new avenues for collaboration in advancing inclusive healthcare. He was accompanied by Dr Babar Qureshi, CBM’s Inclusive Health Director; Jackie Kwesiga, the Country Director of CBM Uganda; and Joy Koech, CBM’s Head of Inclusive Health Programmes.
During his visit, attention was also focused on establishing a cornea transplant facility and capabilities in Uganda—a critical need given the recent enactment of the country’s organ transplant law.
Mengo’s ambition to pioneer a corneal bank and impact corneal transplants in Uganda and across East and Southern Africa aligns with the expertise of Prof. Seitz, whose clinic in Germany is equipped with the latest technology. Dr. Lisbon Aliraki, a Ugandan ophthalmologist at Mengo, received specialised training in donor corneal explantation – an operation to remove all or part of a damaged cornea and replace it with healthy donor tissue – eye bank management, contact lens practice, and corneal transplantation in Germany under Prof. Seitz’s mentorship. This mentorship included mastering innovative running suture techniques to reduce post-transplant refractive error, donor tissue handling, and participation in corneal explantation at a German morgue. Dr. Aliraki also trained in warm versus cold corneal storage methods and other eye transplant procedures, strengthening his capacity to lead Mengo’s transplant initiative.
However, challenges remain. While the legal framework for organ donation exists, limited public awareness about organ donation and the current five-year waiting period for cadaveric donations hinder progress. Dr. Aliraki emphasised that corneal transplants could legally begin today using imported donor tissue, but costs (averaging 8.5–12 million Ugandan shillings) are prohibitive for most patients. Importation delays of 2–4 weeks also render this option ineffective for emergencies like perforated ulcers.
“The real solution lies in establishing a local eye bank,” he stressed. With ongoing training and advocacy, Mengo aims to launch corneal transplant services within the next two years, contingent on policy reforms to shorten the cadaveric donation wait period to 1–2 years.